Graphic plot analysis for estimating binding potential of translocator protein (TSPO) in positron emission tomography studies with [18F]FEDAA1106

PURPOSE [(18)F]FEDAA1106 is expected to be used for evaluating the regional density of the peripheral benzodiazepine receptor (also called TSPO) in several neurodegenerative disorders. Regarding the quantification, direct binding potential (BP(ND)) has been reported to be preferable because of the variation of nondisplaceable distribution volume (V(ND)) among individuals. However, the precise calculation of BP(ND) is difficult in small regions or at voxel levels due to noise. Recently, a new graphical analysis (GA) was proposed to estimate V(ND) in a direct way. In this paper, we evaluated two types of GA for reliable quantification of BP(ND) in PET study with [(18)F]FEDAA1106 using computer simulations and human data. METHODS In the simulations, time-activity curves were generated with various rate constants and noise levels, and the errors of BP(ND) estimated by GA were analyzed by comparing with true values calculated from rate constants given for the simulations. Thereafter, in a human study with [(18)F]FEDAA1106 for healthy volunteers, BP(ND) was estimated by two types of GA for region-of-interest (ROI) data. Parametric images of BP(ND) were generated by two types of GA with or without wavelet-denoising. RESULTS Simulations showed that BP(ND) by GA was well correlated with true values, despite an underestimation. GA reduced unreasonable estimates compared with a conventional nonlinear least-square fitting (NLS), although larger variation of BP(ND) estimates was observed. In a ROI-based analysis of data obtained in a human study, BP(ND)s estimated by GA were well correlated with those generated by NLS, though they were underestimated. Parametric BP(ND) images by GA could be improved with wavelet-denoising. CONCLUSION Graphical analysis could provide BP(ND) values with high stability and simple calculation in both ROI-based and voxel-based analyses of [(18)F]FEDAA1106 data.

[1]  Richard S. J. Frackowiak,et al.  Macrophage and Astrocyte Populations in Relation to [3H]PK 11195 Binding in Rat Cerebral Cortex following a Local Ischaemic Lesion , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[2]  Roger N Gunn,et al.  An 18-kDa Translocator Protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28 , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[3]  Iwao Kanno,et al.  Wavelet denoising for voxel-based compartmental analysis of peripheral benzodiazepine receptors with 18F-FEDAA1106 , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[4]  F. Yasuno,et al.  Increased Binding of Peripheral Benzodiazepine Receptor in Alzheimer's Disease Measured by Positron Emission Tomography with [11C]DAA1106 , 2008, Biological Psychiatry.

[5]  R. Dempsey,et al.  Traumatic Brain Injury Leads to Increased Expression of Peripheral-Type Benzodiazepine Receptors, Neuronal Death, and Activation of Astrocytes and Microglia in Rat Thalamus , 2000, Experimental Neurology.

[6]  B. Gulyás,et al.  A comparative autoradiography study in post mortem whole hemisphere human brain slices taken from Alzheimer patients and age-matched controls using two radiolabelled DAA1106 analogues with high affinity to the peripheral benzodiazepine receptor (PBR) system , 2009, Neurochemistry International.

[7]  A. Guidotti,et al.  Molecular characterization and mitochondrial density of a recognition site for peripheral-type benzodiazepine ligands. , 1988, Molecular pharmacology.

[8]  José Guimón,et al.  Wavelet Analysis of Dynamic PET Data: Application to the Parametric Imaging of Benzodiazepine Receptor Concentration , 2000, NeuroImage.

[9]  I Kanno,et al.  A new graphic plot analysis for cerebral blood flow and partition coefficient with iodine-123-iodoamphetamine and dynamic SPECT validation studies using oxygen-15-water and PET. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  Anthonin Reilhac,et al.  Optimization of dynamic measurement of receptor kinetics by wavelet denoising , 2006, NeuroImage.

[11]  J. Bénavidès,et al.  Increase inω3 (peripheral type benzodiazepine) binding sites in the rat cortex and striatum after local injection of interleukin-1, tumour necrosis factor-α and lipopolysaccharide , 1991, Brain Research.

[12]  B Walder,et al.  Similarity and Robustness of PET and SPECT Binding Parameters for Benzodiazepine Receptors , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  Yun Zhou,et al.  A consistent and efficient graphical analysis method to improve the quantification of reversible tracer binding in radioligand receptor dynamic PET studies , 2009, NeuroImage.

[14]  Tetsuya Suhara,et al.  Development of a new radioligand, N-(5-fluoro-2-phenoxyphenyl)-N-(2-[18F]fluoroethyl-5-methoxybenzyl)acetamide, for pet imaging of peripheral benzodiazepine receptor in primate brain. , 2004, Journal of medicinal chemistry.

[15]  M Slifstein,et al.  Effects of statistical noise on graphic analysis of PET neuroreceptor studies. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  T. Suhara,et al.  [18F]FMDAA1106 and [18F]FEDAA1106: two positron-emitter labeled ligands for peripheral benzodiazepine receptor (PBR). , 2003, Bioorganic & medicinal chemistry letters.

[17]  F E Turkheimer,et al.  Statistical Modeling of Positron Emission Tomography Images in Wavelet Space , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[18]  Lars Farde,et al.  Wavelet-Aided Parametric Mapping of Cerebral Dopamine D2 Receptors Using the High Affinity PET Radioligand [11C]FLB 457 , 2002, NeuroImage.

[19]  F E Turkheimer,et al.  Multiresolution Analysis of Emission Tomography Images in the Wavelet Domain , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[20]  H. Schoemaker,et al.  Specific high-affinity binding sites for [3H]Ro 5-4864 in rat brain and kidney. , 1983, The Journal of pharmacology and experimental therapeutics.

[21]  Andrew F. Laine,et al.  Improving PET-based physiological quantification through methods of wavelet denoising , 2001, IEEE Transactions on Biomedical Engineering.

[22]  D L Alexoff,et al.  A Strategy for Removing the Bias in the Graphical Analysis Method , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[23]  D. Schober,et al.  Peripheral benzodiazepine receptors are colocalized with activated microglia following transient global forebrain ischemia in the rat , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[24]  Ryuji Nakao,et al.  Quantitative Analysis for Estimating Binding Potential of the Peripheral Benzodiazepine Receptor with [11C]DAA1106 , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[25]  B. Gulyás,et al.  Functional neuroimaging in multiple sclerosis with radiolabelled glia markers: Preliminary comparative PET studies with [11C]vinpocetine and [11C]PK11195 in patients , 2008, Journal of the Neurological Sciences.

[26]  Alan A. Wilson,et al.  Translocator Protein (18 kDa) Polymorphism (rs6971) Explains in-vivo Brain Binding Affinity of the PET Radioligand [18F]-FEPPA , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[27]  Harumasa Takano,et al.  A new graphic plot analysis for determination of neuroreceptor binding in positron emission tomography studies , 2010, NeuroImage.

[28]  Alexander Hammers,et al.  A systematic comparison of kinetic modelling methods generating parametric maps for [11C]-(R)-PK11195 , 2007, NeuroImage.

[29]  R B Banati,et al.  PK (‘peripheral benzodiazepine’) – binding sites in the CNS indicate early and discrete brain lesions: microautoradiographic detection of [3H]PK 11195 binding to activated microglia , 1997, Journal of neurocytology.

[30]  D. Duverger,et al.  Imaging of primary and remote ischaemic and excitotoxic brain lesions. An autoradiographic study of peripheral type benzodiazepine binding sites in the rat and cat , 1988, Brain Research.

[31]  K Wienhard,et al.  The ECAT EXACT HR: Performance of a New High Resolution Positron Scanner , 1994, Journal of computer assisted tomography.

[32]  A. Lammertsma,et al.  Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.

[33]  Hans Olsson,et al.  A comparison of recent parametric neuroreceptor mapping approaches based on measurements with the high affinity PET radioligands [11C]FLB 457 and [11C]WAY 100635 , 2006, NeuroImage.

[34]  Robert B. Innis,et al.  SPECT Quantification of [123I]Iomazenil Binding to Benzodiazepine Receptors in Nonhuman Primates: I. Kinetic Modeling of Single Bolus Experiments , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[35]  Roger N Gunn,et al.  In-vivo measurement of activated microglia in dementia , 2001, The Lancet.

[36]  T. Guilarte,et al.  Enhanced expression of peripheral benzodiazepine receptors in trimethyltin-exposed rat brain: a biomarker of neurotoxicity. , 1995, Neurotoxicology.

[37]  V. Ikonomidou,et al.  Translocator Protein PET Imaging for Glial Activation in Multiple Sclerosis , 2011, Journal of Neuroimmune Pharmacology.

[38]  R. Anholt,et al.  Peripheral-type benzodiazepine receptors: autoradiographic localization in whole-body sections of neonatal rats. , 1985, The Journal of pharmacology and experimental therapeutics.

[39]  M E Phelps,et al.  Neuroreceptor Assay with Positron Emission Tomography: Equilibrium versus Dynamic Approaches , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[40]  N. Volkow,et al.  Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[41]  R B Banati,et al.  The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. , 2000, Brain : a journal of neurology.

[42]  G. Fur,et al.  Labelling of “Peripheral‐Type” Benzodiazepine Binding Sites in the Rat Brain By Using [3H]PK 11195, an Isoquinoline Carboxamide Derivative: Kinetic Studies and Autoradiographic Localization , 1983, Journal of neurochemistry.

[43]  T. Guilarte,et al.  Peripheral benzodiazepine receptor imaging in CNS demyelination: functional implications of anatomical and cellular localization. , 2004, Brain : a journal of neurology.

[44]  G. Le Fur,et al.  Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide. I. In vitro studies. , 1983, Life sciences.

[45]  R B Banati,et al.  Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK11195 , 2000, Neurology.

[46]  M. Mintun,et al.  A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography , 1984, Annals of neurology.

[47]  F E Turkheimer,et al.  Modeling Dynamic PET-SPECT Studies in the Wavelet Domain , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[48]  Ryuji Nakao,et al.  Quantitative analyses of 18F-FEDAA1106 binding to peripheral benzodiazepine receptors in living human brain. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[49]  Yoshiro Okubo,et al.  Peripheral benzodiazepine receptors in patients with chronic schizophrenia: a PET study with [11C]DAA1106. , 2010, The international journal of neuropsychopharmacology.

[50]  B. Gulyás,et al.  In vitro evidence for competitive tspo binding of the imaging biomarker candidates vinpocetine and two iodinated daa1106 analogues in post mortem autoradiography experiments on whole hemisphere human brain slices , 2009 .

[51]  Janine Doorduin,et al.  Evaluation of [11C]-DAA1106 for imaging and quantification of neuroinflammation in a rat model of herpes encephalitis. , 2010, Nuclear medicine and biology.

[52]  Robert B. Innis,et al.  Mixed-Affinity Binding in Humans with 18-kDa Translocator Protein Ligands , 2011, The Journal of Nuclear Medicine.

[53]  R. Anholt,et al.  The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane. , 1986, The Journal of biological chemistry.

[54]  C. Carter,et al.  Peripheral type benzodiazepine binding sites are a sensitive indirect index of neuronal damage , 1987, Brain Research.

[55]  Yuji Nagai,et al.  Novel peripheral benzodiazepine receptor ligand [11C]DAA1106 for PET: An imaging tool for glial cells in the brain , 2004, Synapse.

[56]  David J. Schlyer,et al.  Graphical Analysis of Reversible Radioligand Binding from Time—Activity Measurements Applied to [N-11C-Methyl]-(−)-Cocaine PET Studies in Human Subjects , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[57]  Kimberly J. Jenko,et al.  A Genetic Polymorphism for Translocator Protein 18 Kda Affects both in Vitro and in Vivo Radioligand Binding in Human Brain to this Putative Biomarker of Neuroinflammation , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.